THERAPY WITH HYDRAZINOPYRIDAZINE, A NEW ANTIHYPERTENSIVE VASODILATORY AGENT, IN COMBINATION WITH BETA RECEPTOR BLOCKING SUBSTANCESKIRCH W; VON GIZYCKI C.1980; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1980; VOL. 18; NO 5; PP. 233-235; BIBL. 4 REF.Article

Studies on agents with vasodilator and β-blocking activities. IISEKI, T; TAKEZAKI, T; OHUCHI, R et al.Chemical and pharmaceutical bulletin. 1995, Vol 43, Num 2, pp 247-255, issn 0009-2363Article

Synthesis and biotransformation of 3-hydrazinopyridazine drugsPINZA, M; PIFFERI, G.Il Farmaco (Pavia). 1994, Vol 49, Num 11, pp 683-692, issn 0014-827XArticle

Studies on agents with vasodilator and β-blocking activities. ISEKI, T; TAKEZAKI, T; OHUCHI, R et al.Chemical and pharmaceutical bulletin. 1994, Vol 42, Num 8, pp 1609-1616, issn 0009-2363Article

Studies on agents with vasodilator and β-blocking activities. III: Synthesis and activity of optical isomers of TZC-1370SEKI, T; TAKEZAKI, T; OHUCHI, R et al.Chemical and pharmaceutical bulletin. 1995, Vol 43, Num 10, pp 1719-1723, issn 0009-2363Article

Unusual reaction of 2-(trifluoromethyl)-1,2-dihydro-3λ6-thieno-[2,3-c]chromen-3,3,4-triones with hydrazine as a new route to 3-hydrazinopyridazine derivativesSOSNOVSKIKH, Vyacheslav Ya; USACHEV, Boris I; VORONTSOV, Ivan I et al.Journal of organic chemistry. 2002, Vol 67, Num 19, pp 6738-6742, issn 0022-3263, 5 p.Article